01/2024 First patients enrolled in the Gore VBX Forward Clinical Study This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this condition. See more
10/2022 Gore completes enrollment in the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Expand Registry This registry will confirm safety and performance of the VBX Stent Graft in peripheral vessels in patients who require interventional treatment in a variety of applications and diseases. See more
04/2022 GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS See more
11/2020 W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE See more
09/2021 W. L. Gore & Associates enhances GORE® VIABAHN® Endoprosthesis portfolio with lower profile delivery Improvements to large diameter devices include accessibility through smaller sheaths while providing enhanced visualization by adding radiopaque markers See more
04/2025 W. L. GORE & ASSOCIATES LAUNCHES GORE® SYNECOR PREPERITONEAL BIOMATERIAL IN EUROPE, THE MIDDLE EAST AND SOUTH AFRICA See more